ESRX

3 Cheap Stocks to Buy Before They Skyrocket

By Will Healy, InvestorPlace Contributor
Low valuations and strong growth make these cheap stocks attractive buys. Here's what investors need to know about each stock.

5 Stocks to Sell After the Midterm Election

By Larry Ramer, InvestorPlace Contributor
Trump and House Democrats look poised to make deals that will hurt these stocks to sell. Here's what investors need to know.

ExpressScripts Stock Is Trading Flat Despite Earnings Beat

By Karl Utermohlen, InvestorPlace Writer
ExpressScripts stock (ESRX) is not moving late in the day as the company reported its quarterly earnings results, which beat estimates.

Cigna’s Merger With Express Scripts Is Positive for Cigna Stock

By Thomas Scarlett, InvestorPlace Contributor
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.

What Cigna Investors Should Expect From Its Latest Victory

By
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.

Trade of the Day: Express Scripts (ESRX)

By Ken Trester
Express Scripts (NASDAQ:ESRX), a pharmacy benefit management company operating in the United States and Canada, reported its latest earnings this past Wednesday, Aug. 1, and the stock moved sharply lower when the report crossed the tape.

3 Big Stock Charts for Thursday: Express Scripts Holding Co, Alexion Pharmaceuticals and Ventas

By James Brumley, InvestorPlace Feature Writer
Stock charts of Express Scripts, Ventas and Alexion Pharmaceuticals are shaping up as your best bets as the week nears its end.

Cigna Corporation Stock Is Trading at a Steep Discount

By Chris Lau, InvestorPlace Contributor
CI stock is trading at over 20% below its yearly high, and it's discounted ahead of the Express Scripts deal. Investors will want to consider Cigna's long-term upside when the deal closes.

Sell CVS Health Corp and Express Scripts Holding Company as Trump Readies Attack

By Larry Ramer, InvestorPlace Contributor
The Trump administration is targeting PBMs, so it's time to sell PBM stocks, including CVS stock and Express Scripts stock.

Here’s the Truth About Express Scripts Holding Co Stock and PBMs

By Lawrence Meyers, InvestorPlace Contributor
Be wary of a misleading article from Axios about Pharmaceutical Benefit Managers.

The Reviews for the Cigna Corporation-ExpressScripts Deal Are In…And Bad

By Dana Blankenhorn, InvestorPlace Contributor
Analysts are skeptical that buying the largest Pharmacy Benefit Manager will help make Cigna -- one of the smaller health insurers -- more profitable.

5 Growth Stocks in MedTech Set to Scale Higher in 2018

By
The U.S. MedTech markets have been riding high with merger and acquisitions in focus. Compare Brokers...

Cigna Corporation Is Too Late to the Party

By Dana Blankenhorn, InvestorPlace Contributor
Cigna is paying more than its own market cap for ExpressScripts, the largest Pharmacy Benefit Manager.

Stocks Continue to Waver as Trump Unveils Tariffs

By Anthony Mirhaydari, InvestorPlace Market Strategist
Stocks finished mixed on Thursday as President Trump finally unveiled the steel and aluminum tariffs that were hinted at last week.

Express Scripts Holding Co Stock Soars on Cigna Corporation Deal

By William White, InvestorPlace Writer
Express Scripts (ESRX) stock was on the rise Thursday following news of a deal with Cigna (CI) that will have the two companies merging together.

3 Stocks to Watch on Wednesday: Celgene Corporation (CELG), e.l.f. Beauty Inc (ELF) and Express Scripts Holding Company (ESRX)

By Karl Utermohlen, InvestorPlace Writer
Celgene's (CELG) drug application is turned down by FDA, e.l.f. Beauty (ELF) misses revenue outlook and Express Scripts (ESRX) earnings beat estimates.

7 Top Takeover Targets for 2018

By Harriet Lefton, Writer, TipRanks
Morgan Stanley listed 15 prime takeover candidates for the next 12 months and TipRanks shows us which among those are your best investing bets.

Are Healthcare Stocks Terminally Ill?

By John Jagerson and Wade Hansen
Healthcare stocks were rocked hard this week, but they will recover. The news that Amazon, Berkshire Hathaway and JPMorgan are forming their own healthcare company will not hold other healthcare stocks down for the long-term.

PBM Stocks Have Much to Fear from Buffett, JPMorgan, Amazon Venture

By Larry Ramer, InvestorPlace Contributor
The new venture being launched by Warren Buffett, JPMorgan Chase and Amazon.com will badly hurt PBM stocks, including ESRX, CVS and WBA.
Load More